Sothema Strengthens Its Board of Directors with Two New Appointments
The Moroccan pharmaceutical laboratory Sothema is enhancing its governance by announcing the appointment of Aziz Razkaoui and Rakesh Bamzai to its board of directors. These two international profiles will strengthen the group’s strategic expertise in key areas such as renal care and international development.
Aziz Razkaoui: A Recognized Expertise in Renal Care
Co-founder and CEO of Soludia Maghreb, Aziz Razkaoui has over 30 years of experience in dialysis and renal care.
According to Sothema, this expertise is particularly timely as nephrology-related activities become increasingly important in the group’s growth strategy, which aims to enhance its offerings in high-value specialties.
Rakesh Bamzai: An Asset for International Expansion
The board also welcomes Rakesh Bamzai, an experienced leader who has held executive positions in major international pharmaceutical companies for over three decades, including Biocon and Viatris.
With his international experience and knowledge of global pharmaceutical markets, he will guide Sothema in implementing its international expansion strategy and strengthening its presence in new markets.
Governance in Service of Growth
With these two appointments, Sothema reaffirms its commitment to leveraging recognized competencies to support its development, accelerate innovation, and solidify its position among the leading players in the pharmaceutical industry both in Morocco and internationally.
